Program Overview
This webinar was recorded on September 27, 2021.
The Monthly Cardiovascular Forum represents a unique
multidisciplinary collaboration between cardiologists, vascular, and cardiac
surgeons, allowing for a truly comprehensive approach to the management of
aortic and cardiovascular disease.
Lectures, case presentations and panel discussions will be given by
internationally recognized experts who will address the updated knowledge and
cutting-edge technologies in the field, and review standard and emerging
treatments for patients with cardiovascular diseases.
September 27 2021: Impactful Cardiovascular Studies in 2021
This month, we will review two impactful cardiovascular studies: (1) Left Atrial Appendage Occlusion Study (LAAOS) and Mavacamten for HOCM. Join our panel members for a timely and interesting discussion.
Learning Objectives
- Discuss the results of the Left Atrial Appendage Occlusion Trial
- Review Mavacamten Trial for HOCM
Target Audience
This
activity is designed for primary care physicians, cardiologists, interventional
cardiologists, vascular, thoracic and cardiac surgeons, general surgeons,
internists, intensivists, anesthesiologists, podiatrists, cardiac and vascular
NPs and PAs, physical therapists and other medical professionals involved in
the evaluation, diagnosis, and/or management of patients with cardiovascular
disease.
Method of Participation
Once you register, you will receive an email with a link to access the recording.